ADVFN Logo

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.

IRWD Ironwood Pharmaceuticals Inc

8.62
0.00 (0.00%)
Pre Mercado
Última actualización: 04:43:12
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Ironwood Pharmaceuticals Inc IRWD NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.00 0.00% 8.62 04:43:12
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
8.62
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
08/3/202415:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202415:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/3/202415:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202405:00BWIronwood Pharmaceuticals Announces Positive Topline Results..
23/2/202406:30BWIronwood Pharmaceuticals to Present Four Abstracts at the..
15/2/202406:04EDGAR2Form 8-K - Current report
15/2/202406:00BWIronwood Pharmaceuticals Reports Fourth Quarter and Full..
14/2/202420:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202419:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202419:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202419:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202419:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202419:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/2/202415:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/2/202415:13EDGAR2Form 144 - Report of proposed sale of securities
09/2/202415:11EDGAR2Form 144 - Report of proposed sale of securities
09/2/202415:09EDGAR2Form 144 - Report of proposed sale of securities
09/2/202415:05EDGAR2Form 144 - Report of proposed sale of securities
01/2/202415:01BWIronwood Pharmaceuticals to Host Fourth Quarter and Full..
19/1/202415:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202415:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202415:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/1/202415:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202418:00BWIronwood Announces Publication in The Lancet..
08/1/202405:05EDGAR2Form 8-K - Current report
08/1/202405:00BWIronwood Pharmaceuticals Maintains FY 2023 Financial..
03/1/202415:01BWIronwood Pharmaceuticals to Present at the 42nd Annual J.P...
19/12/202315:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/12/202315:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/12/202315:26EDGAR2Form 144 - Report of proposed sale of securities
12/12/202315:01BWIronwood Announces the Completion of Squeeze-Out Merger With..
21/11/202315:01BWIronwood Pharmaceuticals to Participate in the Piper Sandler..
20/11/202315:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/11/202315:05EDGAR2Form 144 - Report of proposed sale of securities
09/11/202315:08EDGAR2Form S-8 - Securities to be offered to employees in employee..
09/11/202315:07EDGAR2Form S-3ASR - Automatic shelf registration statement of..
09/11/202306:07EDGAR2Form 8-K - Current report
09/11/202306:00BWIronwood Pharmaceuticals Reports Third Quarter 2023 Results
26/10/202315:01BWIronwood Pharmaceuticals to Host Third Quarter 2023 Investor..
23/10/202306:30BWIronwood Releases New IBS-C and CIC Data at the American..
16/10/202305:00BWIronwood Pharmaceuticals Presents Positive Final Data from..
05/10/202306:30BWIronwood to Present New Data at NASPGHAN Annual Meeting..
19/9/202316:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/9/202316:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/9/202315:30EDGAR2Form 8-K/A - Current report: [Amend]
31/8/202315:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/8/202315:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/8/202315:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/8/202315:02EDGAR2Form 144 - Report of proposed sale of securities
09/8/202315:02EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Su Consulta Reciente

Delayed Upgrade Clock